Skip to main content

Life threatening agranulocytosis and toxic epidermal necrolysis during low dose penicillamine therapy

Summary

A case of life-threatening agranulocytosis due to low dose penicillamine therapy is reported. The patient, who had primary biliary cirrhosis, presented with toxic epidermal necrolysis (TEN—staphylococcal scalded skin syndrome). Agranulocytosis had occurred following a 7 week course of 250 mgs penicillamine daily. The white cell count rose from the fifth day following treatment with antibiotics and granulocyte transfusions. Recovery was complicated by hepatic decompensation and pre-coma, massive gastrointestinal bleeding, myocardial infarction, renal tubular necrosis and pyomyositis.

This is a preview of subscription content, access via your institution.

References

  • Corcos, J., Soler-Bechera, J., Mayer, K., Feyberg R. H., Goldstein, R. and Jaffe, I. 1964. Neutrophilic agranulocytosis during administration of penicillamine. J. Am Med. Ass. 189, 265.

    CAS  Google Scholar 

  • Deiss, A., Lynch, R. E., Lee, G. R. and Cartwright, G. E. 1971. Long-term therapy of Wilson's disease. Anns. Int. Med. 75, 57.

    CAS  Google Scholar 

  • Editorial. 1978. Penicillamine—its place in rheumatology. Brit. Med. J. i, 131.

  • Epstein, O., de Villiers, D., Jain, S., Potter, B. J., Thomas, H. C. and Sherlock, S. 1979. Reduction of immune complexes and immunoglobulins induced by D-penicillamine in primary biliary cirrhosis. N. Eng. J. Med. 300, 274.

    CAS  Google Scholar 

  • Jaffe, I. A. 1975. The technique of penicillamine administration in rheumatoid arthritis. Arth. Rheum., 18, 513.

    Article  CAS  Google Scholar 

  • Kay, A. G. 1979. Myelotoxicity of D-penicillamine. Annals of Rheum. Dis. 38, 232.

    Article  CAS  Google Scholar 

  • Lyell, A. 1979. Toxic epidermal necrolysis (the scalded skin syndrome): a reappraisal. Brit. J. Derm. 100, 69.

    PubMed  Article  CAS  Google Scholar 

  • Matloff, D., Resnick, R., Alpert, E. and Kaplan, M. 1979. D-penicillamine does not alter the course of primary biliary cirrhosis. Gastroenterology 77, A26.

    Google Scholar 

  • Multicentre Trial Group. 1973. Controlled trial of D-penicillamine in severe rheumatoid arthritis. Lancet i, 275.

    Article  Google Scholar 

  • Shapiro, J. M., Smith, H. and Schaffner, F. 1979. Serum bilirubin: a prognostic factor in primary biliary cirrhosis. GUT 20, 137.

    PubMed  Article  CAS  Google Scholar 

  • Stein, H. B., Patterseon, A. C., Offer, R. C., Atkins, C. J., Teufel, A. and Robinson, H. S. 1980. Adverse effects of D-penicillamine in rheumatoid arthritis. Ann Int. Med. 92, 24.

    PubMed  CAS  Google Scholar 

  • Stephens, A. D. and Watts, R. W. 1971. The treatment of cystinuria with n-acetyl D-penicillamine, a comparison with the results of D-penicillamine treatment. Quart. J. Med. 40, 355.

    PubMed  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ward, K., Weir, D.G. Life threatening agranulocytosis and toxic epidermal necrolysis during low dose penicillamine therapy. I.J.M.S. 150, 252–253 (1981). https://doi.org/10.1007/BF02938248

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02938248

Keywords

  • Primary Biliary Cirrhosis
  • Agranulocytosis
  • Penicillamine
  • Toxic Epidermal Necrolysis
  • Fusidic Acid